Research Topic

Glycans in Diseased and Healthy Brains

About this Research Topic

Alzheimer’s, Parkinson’s and Huntington’s disease are this century’s most common Neurodegenerative Diseases (NDs) affecting the elderly population. These devastating neurodegenerative diseases are associated with progressive brain cell loss, and other deleterious processes leading to a number of different symptoms, affecting the daily independent life of patients. These NDs cause a huge economic burden, and stress on caregivers and family members, representing an unprecedented global public health challenge. With so far only ameliorating treatments available, further research into developing novel and effective disease-modifying therapies is becoming more crucial. As such, the discovery of new causative agents involved in the onset and progression of these neurodegenerative disorders is necessary to identify new therapeutic approaches.

One of such targets could be glycans, which are carbohydrates attached to proteins. The glycan compositions at proteins play major metabolic, structural, and physical roles in all biological systems. Specifically, in neurodegenerative diseases, they have gained increasing attention to further the understanding of disease progression as well as potential biomarkers for early disease detection. The particular aberrant protein glycosylations and consequently changes to the glycome are unique for each neurodegenerative disease. These unique signatures can be beneficial for subtyping such diseases and providing new insights into pathomechanisms. This research has gained recent attention through several studies investigating the glycoproteomics.

In this Research Topic, we aim at Research Articles and Reviews that focus on the role of glycans in neurodegenerative diseases. This includes both translational strategies in order to identify new biomarkers as well as understanding the diverse glycan biology and its role in the onset and the progression of the pathology.


Keywords: Glycans, neurodegeneration, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, proteomics


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Alzheimer’s, Parkinson’s and Huntington’s disease are this century’s most common Neurodegenerative Diseases (NDs) affecting the elderly population. These devastating neurodegenerative diseases are associated with progressive brain cell loss, and other deleterious processes leading to a number of different symptoms, affecting the daily independent life of patients. These NDs cause a huge economic burden, and stress on caregivers and family members, representing an unprecedented global public health challenge. With so far only ameliorating treatments available, further research into developing novel and effective disease-modifying therapies is becoming more crucial. As such, the discovery of new causative agents involved in the onset and progression of these neurodegenerative disorders is necessary to identify new therapeutic approaches.

One of such targets could be glycans, which are carbohydrates attached to proteins. The glycan compositions at proteins play major metabolic, structural, and physical roles in all biological systems. Specifically, in neurodegenerative diseases, they have gained increasing attention to further the understanding of disease progression as well as potential biomarkers for early disease detection. The particular aberrant protein glycosylations and consequently changes to the glycome are unique for each neurodegenerative disease. These unique signatures can be beneficial for subtyping such diseases and providing new insights into pathomechanisms. This research has gained recent attention through several studies investigating the glycoproteomics.

In this Research Topic, we aim at Research Articles and Reviews that focus on the role of glycans in neurodegenerative diseases. This includes both translational strategies in order to identify new biomarkers as well as understanding the diverse glycan biology and its role in the onset and the progression of the pathology.


Keywords: Glycans, neurodegeneration, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, proteomics


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

11 November 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

11 November 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..